- Angst J (1992) Epidemiology of depression. Psychopharmacol 102: S71-S74.
- Montgomery SA (1992) Suicide and antidepressants. Drugs 43 (suppl 2):24-31.
- Speight TM, Holford NHG (eds) (1997) Avery's Drug Treatment, (4th edn). Adis International Ltd, New Zealand.
- Derivan AT (1995) Antidepressants: can we determine how quickly they work? Issues from the literature. Psychopharmacol Bull 31: 23-8.
- Montgomery SA (1997) Reboxetine: additional benefits to the depressed patient J Psychopharmacol 11 (suppl): S9-S15.
- Mucci M (1997) Reboxetine: a review of antidepressant tolerability.Eur Neuropsychopharmacd 7 (suppl 1): S33-S37.
- Versiani M, Chouinard G, Amin M (2000) A double-blind, placebo-controlled study with reboxetine in inpatients with severe major depressive disorder. J Clin Psychopharmacol 20: 28-34.
- Hamilton H (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56-62.
- Zung WWK, Durham NC (1965) A self-rating depression scale. Arch Gen Psychiatry 12: 61-70.
- Guy W (1976) ECDEU assessment manual for psychopharmacology revised Maryland: National Institute of Mental Health.
- Clerc GE, Ruimy P, Verdeau-Pailles J (1994) A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia. Int Clin Psychopharmacol 9: 139-43.
- Guelfi JD, White C, Hackett D et al (1995) Effectiveness of venlafaxine in patients hospitalized for major depression and melancholia.J Clin Psychiatry 56: 450-8.
- Dubini A, Bosc M, Polin V (1997) Noradrenaline-selective versus serotonin-selective antidepressant therapy: differential effects on social functioning. J Psychopharmacol 11 (suppl 4): S17-S23.
- Brugha TS, Bebbington PE, Stretch DD et al (1997) Predicting the short-term outcome of first episodes and recurrences of clinical depression: a prospective study of life events, difficulties, and social support networks. J Clin Psychiatry 58: 298-306.
The selective noradrenaline re-uptake inhibitor reboxetine has an early onset of antidepressant action
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.